Other TIGIT drugs from Merck & Co, Bristol-Myers Squibb/Agenus, Gilead/Arcus, and Mereo Biopharma are also in clinical development. Image. Phil Taylor. 13 May, 2022. GlaxoSmithKline.

Stock market today: S&P 500 starts June on front foot after cutting losses By Investing.com - Jun 02, 2025 137 Investing.com--The S&P 500 cut losses Monday, shrugging off rising tensions between ...

SHOPPING: Sony has been on the forefront for some of the best headphones ever made with its WH-1000X series, but ever since its last release in May 2022, fans have been wondering when the next ...